Abrdn Life Sciences Investors (HQL) Competitors

Abrdn Life Sciences Investors (NYSE:HQL) and Central Securities (NYSE:CET) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, community ranking, dividends, institutional ownership, risk and earnings.

Does the MarketBeat Community believe in HQL or CET?

Abrdn Life Sciences Investors received 95 more outperform votes than Central Securities when rated by MarketBeat users.

Company	Underperform	Outperform
Abrdn Life Sciences Investors	Outperform Votes 95 68.35%	Underperform Votes 44 31.65%
Central Securities	N/A	N/A

Is HQL or CET more profitable?

Company	Net Margins	Return on Equity	Return on Assets
Abrdn Life Sciences Investors	N/A	N/A	N/A
Central Securities	N/A	N/A	N/A

Which has more risk and volatility, HQL or CET?

Abrdn Life Sciences Investors has a beta of 0.73, meaning that its share price is 27% less volatile than the S&P 500. Comparatively, Central Securities has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500.

Do analysts rate HQL or CET?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abrdn Life Sciences Investors	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Central Securities	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Is HQL or CET a better dividend stock?

Abrdn Life Sciences Investors pays an annual dividend of $1.49 per share and has a dividend yield of 11.2%. Central Securities pays an annual dividend of $1.85 per share and has a dividend yield of 4.3%.

Which has higher valuation and earnings, HQL or CET?

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abrdn Life Sciences Investors	N/A	N/A	N/A	N/A	N/A
Central Securities	N/A	N/A	N/A	N/A	N/A

Does the media refer more to HQL or CET?

In the previous week, Central Securities had 1 more articles in the media than Abrdn Life Sciences Investors. MarketBeat recorded 5 mentions for Central Securities and 4 mentions for Abrdn Life Sciences Investors. Abrdn Life Sciences Investors' average media sentiment score of 1.32 beat Central Securities' score of -0.16 indicating that Abrdn Life Sciences Investors is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abrdn Life Sciences Investors	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Central Securities	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do institutionals and insiders believe in HQL or CET?

32.2% of Abrdn Life Sciences Investors shares are held by institutional investors. Comparatively, 8.7% of Central Securities shares are held by institutional investors. 10.1% of Abrdn Life Sciences Investors shares are held by company insiders. Comparatively, 10.3% of Central Securities shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Abrdn Life Sciences Investors beats Central Securities on 4 of the 7 factors compared between the two stocks.